| | | | | | | | | | |
| | |
 | Issue Date FY: 2021 ( Subtotal = $4,773,932 ) |
| | 2021 | 2021 | R03DE030257 | Germline risk of oral and oropharyngeal cancers across diverse populations | 000 | 1 | NIH | 7/23/2021 | 279551881 | $113,423 |
| | 2021 | 2021 | R01DE025712 | The role of germline and somatic DNA mutations in oral and oropharyngeal cancers | 002 | 5 | NIH | 12/11/2020 | 279551881 | -$59,189 |
| | 2021 | 2021 | R01DE025712 | The role of germline and somatic DNA mutations in oral and oropharyngeal cancers | 002 | 5 | NIH | 12/11/2020 | 279551881 | $14,829 |
| | 2021 | 2021 | R01DE025712 | The role of germline and somatic DNA mutations in oral and oropharyngeal cancers | 000 | 5 | NIH | 11/18/2020 | 279551881 | $148,284 |
| | 2021 | 2021 | R01DE025712 | The role of germline and somatic DNA mutations in oral and oropharyngeal cancers | 000 | 5 | NIH | 11/18/2020 | 279551881 | $531,593 |
| | 2021 | 2021 | UH3CA202721 | Development, field testing and evaluation of the efficacy of a hand-held, portable and affordable thermo-coagulator to prevent cervical cancer in low- and middle-income countries | 000 | 5 | NIH | 6/4/2021 | 279551881 | $350,000 |
| | 2021 | 2021 | R01CA244559 | African Breast Cancer - Disparities in Outcomes - Plus (ABC-DO Plus) | 000 | 2 | NIH | 6/3/2021 | 279551881 | $429,418 |
| | 2021 | 2021 | R01CA244559 | African Breast Cancer - Disparities in Outcomes - Plus (ABC-DO Plus) | 001 | 2 | NIH | 6/4/2021 | 279551881 | $328,943 |
| | 2021 | 2021 | R01CA033193 | IARC Monographs on the Identification of Carcinogenic Hazards to Humans | 001 | 39 | NIH | 9/10/2021 | 279551881 | $100,000 |
| | 2021 | 2021 | R01CA033193 | IARC Monographs on the Identification of Carcinogenic Hazards to Humans | 000 | 39 | NIH | 8/2/2021 | 279551881 | $880,253 |
| | 2021 | 2021 | U01CA257679 | InterLymph Consortium: interrogating pleiotropy and gene by environment interactions among hematopoietic malignancies. | 000 | 1 | NIH | 9/3/2021 | 279551881 | $495,637 |
| | 2021 | 2021 | U01CA257679 | InterLymph Consortium: interrogating pleiotropy and gene by environment interactions among hematopoietic malignancies. | 001 | 1 | NIH | 9/7/2021 | 279551881 | $75,247 |
| | 2021 | 2021 | UH3CA202730 | Development and clinical validation of a multi-type HPV E6/E7 oncoprotein test for cervical cancer screening and triage in low- and middle-income countries | 001 | 5 | NIH | 6/4/2021 | 279551881 | $350,000 |
| | 2021 | 2021 | UH3CA202730 | Development and clinical validation of a multi-type HPV E6/E7 oncoprotein test for cervical cancer screening and triage in low- and middle-income countries | 000 | 5 | NIH | 6/3/2021 | 279551881 | $756,503 |
| | 2021 | 2021 | R21CA256902 | The role of Epstein Barr Virus and Human Papilloma Virus Co-infection in Conjunctival Squamous Cell Carcinoma. | 000 | 1 | NIH | 6/25/2021 | 279551881 | $198,631 |
| | 2021 | 2021 | R01DE025712 | The role of germline and somatic DNA mutations in oral and oropharyngeal cancers | 003 | 5 | NIH | 6/3/2021 | 279551881 | $60,714 |
| | 2021 | 2021 | R01DE025712 | The role of germline and somatic DNA mutations in oral and oropharyngeal cancers | 003 | 5 | NIH | 6/3/2021 | 279551881 | $9,898 |
| | 2021 | 2020 | R01DE025712 | The role of germline and somatic DNA mutations in oral and oropharyngeal cancers | 001 | 4 | NIH | 12/10/2020 | 279551881 | -$10,252 |
| | 2021 | 2020 | R03CA245979 | Evaluating risk prediction models for use in lung cancer screening in diverse populations around the world | 000 | 1 | NIH | 11/3/2020 | 279551881 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $3,500,092 ) |
| | 2020 | 2020 | R01DE025712 | The role of germline and somatic DNA mutations in oral and oropharyngeal cancers | 002 | 4 | NIH | 7/22/2020 | 279551881 | $56,970 |
| | 2020 | 2020 | R03CA245979 | Evaluating risk prediction models for use in lung cancer screening in diverse populations around the world | 000 | 1 | NIH | 9/8/2020 | 279551881 | $112,170 |
| | 2020 | 2020 | U01CA033193 | Evaluation of Carcinogenic Risks to Humans | 001 | 38 | NIH | 9/2/2020 | 279551881 | $100,000 |
| | 2020 | 2020 | U01CA033193 | Evaluation of Carcinogenic Risks to Humans | 001 | 38 | NIH | 9/2/2020 | 279551881 | $800,230 |
| | 2020 | 2020 | UH3CA202730 | Development and clinical validation of a multi-type HPV E6/E7 oncoprotein test for cervical cancer screening and triage in low- and middle-income countries | 001 | 4 | NIH | 6/26/2020 | 279551881 | $850,346 |
| | 2020 | 2020 | UH3CA202721 | Development, field testing and evaluation of the efficacy of a hand-held, portable and affordable thermo-coagulator to prevent cervical cancer in low- and middle-income countries | 000 | 5 | NIH | 7/29/2020 | 279551881 | $489,630 |
| | 2020 | 2020 | R01DE025712 | The role of germline and somatic DNA mutations in oral and oropharyngeal cancers | 001 | 4 | NIH | 2/14/2020 | 279551881 | $61,316 |
| | 2020 | 2020 | R01DE025712 | The role of germline and somatic DNA mutations in oral and oropharyngeal cancers | 000 | 4 | NIH | 12/12/2019 | 279551881 | $551,831 |
| | 2020 | 2020 | R01CA244559 | African Breast Cancer - Disparities in Outcomes - Plus (ABC-DO Plus) | 000 | 1 | NIH | 7/22/2020 | 279551881 | $477,599 |
| | 2020 | 2019 | UH3CA202730 | Development and clinical validation of a multi-type HPV E6/E7 oncoprotein test for cervical cancer screening and triage in low- and middle-income countries | 000 | 3 | NIH | 3/17/2020 | 279551881 | $0 |
| | 2020 | 2019 | U01CA033193 | Evaluation of Carcinogenic Risks to Humans | 000 | 38 | NIH | 1/17/2020 | 279551881 | $0 |
| | 2020 | 2019 | U01CA033193 | Evaluation of Carcinogenic Risks to Humans | 000 | 38 | NIH | 1/17/2020 | 279551881 | $0 |
| | 2020 | 2018 | U01CA195603 | Biomarkers of human papillomavirus (HPV) infection and risk of two increasing cancers | 000 | 4 | NIH | 7/7/2020 | 279551881 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $3,747,605 ) |
| | 2019 | 2019 | U01CA033193 | Evaluation of Carcinogenic Risks to Humans | 001 | 38 | NIH | 8/23/2019 | 279551881 | $793,966 |
| | 2019 | 2019 | U01CA033193 | Evaluation of Carcinogenic Risks to Humans | 001 | 38 | NIH | 8/23/2019 | 279551881 | $100,000 |
| | 2019 | 2019 | UH3CA202730 | Development and clinical validation of a multi-type HPV E6/E7 oncoprotein test for cervical cancer screening and triage in low- and middle-income countries | 000 | 3 | NIH | 7/4/2019 | 279551881 | $874,156 |
| | 2019 | 2019 | UH3CA202730 | Development and clinical validation of a multi-type HPV E6/E7 oncoprotein test for cervical cancer screening and triage in low- and middle-income countries | 001 | 3 | NIH | 8/14/2019 | 279551881 | $0 |
| | 2019 | 2019 | UH3CA202721 | Development, field testing and evaluation of the efficacy of a hand-held, portable and affordable thermo-coagulator to prevent cervical cancer in low- and middle-income countries | 001 | 3 | NIH | 3/18/2019 | 279551881 | $212,479 |
| | 2019 | 2019 | UH3CA202721 | Development, field testing and evaluation of the efficacy of a hand-held, portable and affordable thermo-coagulator to prevent cervical cancer in low- and middle-income countries | 002 | 4 | NIH | 9/5/2019 | 279551881 | $719,063 |
| | 2019 | 2019 | R01AA024770 | A pooling project on alcohol use and risk of cancers with inconsistent prior evidence, with an emphasis in non-smokers. | 000 | 4 | NIH | 7/23/2019 | 279551881 | $416,713 |
| | 2019 | 2019 | R01DE025712 | The role of germline and somatic DNA mutations in oral and oropharyngeal cancers | 000 | 3 | NIH | 12/12/2018 | 279551881 | $631,228 |
| | 2019 | 2018 | U01CA033193 | Evaluation of Carcinogenic Risks to Humans | 000 | 37 | NIH | 7/11/2019 | 279551881 | $0 |
| | 2019 | 2018 | U01CA033193 | Evaluation of Carcinogenic Risks to Humans | 000 | 37 | NIH | 7/11/2019 | 279551881 | $0 |
| | 2019 | 2018 | UH3CA202721 | Development, field testing and evaluation of the efficacy of a hand-held, portable and affordable thermo-coagulator to prevent cervical cancer in low- and middle-income countries | 000 | 3 | NIH | 1/7/2019 | 279551881 | $6,943 |
| | 2019 | 2017 | UH2CA202730 | Development and clinical validation of a multi-type HPV E6/E7 oncoprotein test for cervical cancer screening and triage in low- and middle-income countries | 000 | 2 | NIH | 7/2/2019 | 279551881 | $0 |
| | 2019 | 2017 | UH2CA202721 | Development, field testing and evaluation of the efficacy of a hand-held, portable and affordable thermo-coagulator to prevent cervical cancer in low- and middle-income countries | 000 | 2 | NIH | 1/7/2019 | 279551881 | -$6,943 |
|
| Issue Date FY: 2018 ( Subtotal = $2,926,273 ) (Continued on the next page) |
| | 2018 | 2018 | R01DE025712 | The role of germline and somatic DNA mutations in oral and oropharyngeal cancers | 001 | 2 | NIH | 4/20/2018 | 279551881 | $63,019 |
|
